Ian Fleming

Dr. Ian Fleming is a Senior Lecturer at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition, specializing in nuclear medicine and oncology research. His work focuses on developing and validating PET radiotracers for cancer imaging, particularly targeting tumor hypoxia, cell proliferation, and angiogenesis.

• Institution: University of Aberdeen
• School: School of Medicine, Medical Sciences and Nutrition
• Research Focus: PET tracer development for oncology applications
• Current Projects: Cell proliferation, hypoxia, and angiogenesis imaging
• Collaborators: Prof Fiona Gilbert (Cambridge), Prof Paula Ghaneh (Liverpool), Prof David O'Hagan (St Andrews)

Dr. Fleming's research centers on molecular imaging techniques for cancer diagnostics and treatment monitoring. His laboratory develops novel PET radiotracers to visualize tumor hypoxia and angiogenesis, with current projects examining hypoxic subtypes in breast cancer and validating FLT-PET as a predictive biomarker. His work bridges radiochemistry and clinical oncology through collaborations with multiple institutions and pharmaceutical partners.

His publication trends reveal consistent contributions to nuclear medicine journals, with recent emphasis on hypoxia imaging tracers (FAZA, FLT), RGD-based angiogenesis probes, and enzymatic radiolabeling techniques. Key research areas include tumor microenvironment characterization, biomarker validation, and translational applications of molecular imaging.

• Validation of FLT-PET as predictive biomarker in breast cancer (Cancer Research UK)
• FAZA as PET tracer for colorectal carcinoma hypoxia (NHS Grampian)
• Detection of hypoxia in breast cancer (Breast Cancer Campaign)
• Novel αvβ3 radiotracer development (KETF)
• HER2 imaging for gastroesophageal adenocarcinomas (NHS Grampian)

Dr. Fleming actively contributes to medical education as Programme Coordinator for BT3006 and BT5007, Course Coordinator for PA3802 and BP5003, and lecturer for SM2501. His educational leadership extends to coordinating the Hotstart programme and shaping pharmacology curricula at the University of Aberdeen.